Corcept Therapeutics (CORT) Tops Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $118.10 --0%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q3 EPS of $0.28, $0.06 better than the analyst estimate of $0.22. Revenue for the quarter came in at $123.6 million versus the consensus estimate of $119.71 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Assumes Corcept Therapeutics (CORT) at Buy
- Target raises full-year sales forecast amid ongoing turnaround drive
- Benchmark Reiterates Hold Rating on Bio-Techne Corp. (TECH)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
